OraSure to Announce Third Quarter 2024 Financial Results and Host Earnings Call on November 6th

Rhea-AI Summary

OraSure Technologies, Inc. (NASDAQ: OSUR) has announced its upcoming earnings conference call for the third quarter 2024. The call is scheduled for November 6, 2024, at 5 p.m. ET. Investors and interested parties can access the webcast through OraSure's investor relations website. The webcast link will be available at https://orasure.gcs-web.com/events-and-presentations, with registration required at least 10 minutes before the call starts. The webcast will be archived on the website for approximately 90 days after the event. For those wishing to ask questions during the call, a pre-registration link is provided. After registering, participants will receive access details via email.

BETHLEHEM, Pa., Oct. 22, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering third quarter 2024 financial results and certain business developments for 5 p.m. ET on November 6, 2024.

A webcast of the conference call will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations. Please click on the webcast link and follow the prompts for registration and access at least 10 minutes prior to the call. The webcast will be archived on OraSure’s website shortly after the call has ended and will be available for approximately 90 days.

For participants interested in asking questions during the conference call, please follow the link below to pre-register. After registering, you will be provided with access details via email.

https://register.vevent.com/register/BIbe76f335a1d54f62abf8377abec292b4

About OraSure Technologies, Inc. 
OraSure Technologies, Inc. (“OraSure”) transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. OraSure improves access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. OraSure, together with its wholly-owned subsidiary, DNA Genotek Inc., is a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct to consumers. For more information on OraSure Technologies, please visit www.orasure.com.

Investor Contact:	Media Contact:
Jason Plagman	Amy Koch
VP, Investor Relations	Director, Corporate Communications
investorinfo@orasure.com	media@orasure.com

FAQ

When will OraSure Technologies (OSUR) announce its Q3 2024 financial results?

OraSure Technologies (OSUR) will announce its third quarter 2024 financial results on November 6, 2024, during an earnings conference call scheduled for 5 p.m. ET.

How can investors access OraSure's (OSUR) Q3 2024 earnings call?

Investors can access OraSure's Q3 2024 earnings call via a webcast on the company's investor relations website at https://orasure.gcs-web.com/events-and-presentations. Registration is required at least 10 minutes before the call starts.

Will OraSure's (OSUR) Q3 2024 earnings call be available for replay?

Yes, OraSure's Q3 2024 earnings call webcast will be archived on the company's website shortly after the call ends and will be available for approximately 90 days.

How can participants ask questions during OraSure's (OSUR) Q3 2024 earnings call?

Participants who wish to ask questions during OraSure's Q3 2024 earnings call must pre-register using a provided link. After registration, they will receive access details via email.